EUVIMEDEUVIMED entdecken
Crossref

Significance of Organic Anion Transporter 2 and Organic Cation Transporter 2 in Creatinine Clearance: Mechanistic Evaluation Using Freshly Prepared Human Primary Renal Proximal Tubule Cells

Sumathy Mathialagan, Git Chung, Keith Pye, A David Rodrigues, Manthena V S Varma iD, Colin Brown

The Journal of Pharmacology and Experimental Therapeutics · 2024-01 · 388 (1) · 201-208

DOI: 10.1124/jpet.123.001890 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024-01. Verfasst von Sumathy Mathialagan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medicine Design, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut (S.M., A.D.R., M.V.S.V.); and Newcells Biotech Limited, The Biosph…. Hauptthemen laut MEDLINE: Metformin, Organic Anion Transporters. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Creatinine, a clinical marker for kidney function, is predominantly cleared by glomerular filtration, with active tubular secretion contributing to about 30% of its renal clearance. Recent studies suggested the potential involvement of organic anion transporter (OAT)2, in addition to the previously known organic cation transporter (OCT)2-mediated basolateral uptake, in creatinine active secretion. Here we characterized the transport mechanisms of creatinine using transfected human embryonic kidney (HEK)293 cells and freshly prepared human primary renal proximal tubule epithelial cells (hPTCs). Creatinine showed transport by OAT2 in transfected HEK293 cells. In addition, both creatinine and metformin showed transport by OCT2 and multidrug and toxin extrusion pump (MATE)1 and MATE2K, while penciclovir was selective for OAT2. Time-dependent cell accumulation was observed for creatinine and metformin in hPTCs. Their accumulation was increased by pyrimethamine but inhibited by decynium-22, likely due to differential inhibition of OCT2 versus MATEs. Additionally, indomethacin (an OAT2 inhibitor) reduced penciclovir uptake (∼75%) in hPTCs illustrating functional OAT2 activity. However, no modulation of creatinine and metformin cell accumulation was apparent with indomethacin. Creatinine transport characteristics in the presence of inhibitors approached those of metformin, an OCT2/MATE substrate, but were distinct from those of penciclovir, an OAT2-selective substrate. Moreover, indomethacin showed no significant effect on the basolateral-to-apical transport and net secretion of creatinine across hPTC monolayers. Collectively, the functional studies suggest OCT2 as the primary basolateral uptake mechanism and that OAT2 has a minimal role, in creatinine renal secretion. Our results highlight the utility of hPTCs to enable the functional assessment of renal transport mechanisms. SIGNIFICANCE STATEMENT: Our results obtained with primary hPTCs indicate that OCT2/MATE (vs. OAT2) play a major role in the active renal secretion of creatinine. Quantitative pharmacokinetic models should therefore focus on OCT2/MATE when describing serum creatinine and creatinine clearance modulation by inhibitor drugs and genotype- or disease-related activity changes. The present study highlights the utility of freshly isolated hPTCs to support solute carrier phenotyping to enable the functional assessment of renal transport mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminOrganic Anion TransportersHumansOrganic Cation Transporter 2CreatinineOrganic Cation Transport ProteinsHEK293 CellsKidneyIndomethacin

Substanzen

Organic Cation Transporter 2CreatinineOrganic Cation Transport ProteinsMetforminIndomethacinOrganic Anion Transporters

Autor:innen und Institutionen

  • Medicine Design, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut (S.M., A.D.R., M.V.S.V.); and Newcells Biotech Limited, The Biosphere, Newcastle Upton Tyne, United Kingdom (G.C., K.P., C.B.).
  • Medicine Design, Pfizer Research and Development, Pfizer Inc., Groton, Connecticut (S.M., A.D.R., M.V.S.V.); and Newcells Biotech Limited, The Biosphere, Newcastle Upton Tyne, United Kingdom (G.C., K.P., C.B.) colin.bro…

ORCID-Profile: Manthena V S Varma

Zitieren

APA

Mathialagan, S., Chung, G., Pye, K., Rodrigues, A. D., Varma, M. V. S., & Brown, C. (2024). Significance of Organic Anion Transporter 2 and Organic Cation Transporter 2 in Creatinine Clearance: Mechanistic Evaluation Using Freshly Prepared Human Primary Renal Proximal Tubule Cells. The Journal of Pharmacology and Experimental Therapeutics, 388(1), 201-208. https://doi.org/10.1124/jpet.123.001890

Vancouver

Mathialagan S, Chung G, Pye K, Rodrigues AD, Varma MVS, Brown C. Significance of Organic Anion Transporter 2 and Organic Cation Transporter 2 in Creatinine Clearance: Mechanistic Evaluation Using Freshly Prepared Human Primary Renal Proximal Tubule Cells. The Journal of Pharmacology and Experimental Therapeutics. 2024;388(1):201-208. doi:10.1124/jpet.123.001890

BibTeX
@article{Mathialagan2024,
  author = {Mathialagan, Sumathy and Chung, Git and Pye, Keith and Rodrigues, A David and Varma, Manthena V S and Brown, Colin},
  title = {Significance of Organic Anion Transporter 2 and Organic Cation Transporter 2 in Creatinine Clearance: Mechanistic Evaluation Using Freshly Prepared Human Primary Renal Proximal Tubule Cells},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2024},
  volume = {388},
  number = {1},
  pages = {201--208},
  doi = {10.1124/jpet.123.001890}
}
Kostenlos starten →